ABSTRACT 2-Azidoadenine [32P]nucleotide was bound specifically at catalytic or noncatalytic nucleotide binding sites on beef heart mitochondrial F. ATPase. In both cases, photolysis resulted in nearly exclusive labeling of the I8 subunit. The modified enzyme was digested with trypsin, and labeled peptides were purified by reversed-phase high-pressure liquid chromatography. Amino acid sequence analysis of the major 32P-labeled tryptic fragments showed 13-subunit Tyr-368 to be present at noncatalytic sites and /8 Tyr-345 to be present at catalytic sites. From the relationship between the degree of inhibition and extent of modification, it is estimated that one-third of the catalytic sites or two-thirds of the noncatalytic sites must be modified to give near-complete inhibition of catalytic activity.
a3f33y&e subunit structure. F1 contains the catalytic sites for ATP synthesis, but when detached from the membrane it is only capable of net ATP hydrolysis (1, 2).
Of the six nucleotide binding sites present on the beef heart mitochondrial enzyme, MF1, only three sites exchange bound nucleotide rapidly during hydrolysis of MgATP at pH 8.0 (3) . Evidence has been presented that at least two (4) (5) (6) and probably all three (7) (8) (9) (10) (11) (12) of the exchangeable sites participate sequentially in catalysis at high substrate concentration. The three nonexchangeable sites, referred to here as noncatalytic sites, have been suggested to play a structural or regulatory role (for example, see refs. 13 and 14) .
A valuable approach to the characterization of nucleotide binding sites on F1 has been the use of affinity and photoaffinity analogs (15) . Perhaps the most promising probes are the 2-azidoadenine nucleotides (11, 16, 17) . Their anti conformation resembles that of F1-bound ADP and ATP; thus, they bind very tightly and serve as good substrates (18) . Procedures described by Kironde and Cross (19) allow the specific loading of 2-azidoadenine nucleotides at noncatalytic or catalytic sites on MF1. Photolysis results in the labeling of the ,B subunit in each case, but different labeled peptides were obtained in partial Staphylococcus aureus V8 protease digests (20) . In this paper, we show that the labeled catalytic and noncatalytic site residues are on adjacent tryptic peptides corresponding to those labeled by 5'-[p-(fluorosulfonyl)benzoyl]inosine (FSBI) and 5'-[p-(fluorosulfonyl)benzoyl]-adenosine (ESBA), respectively (21) . The catalytic-site peptide corresponds to the single tryptic peptide detected with 2-azido-ADP labeling by Garin et al. (22) . We also report here the effects of derivatization on catalytic activity.
MATERIALS AND METHODS
Preparation of MF1. MF1 was isolated from beef heart mitochondria as described (23) . MF1 containing one vacant noncatalytic site and one filled catalytic site (MF1 [2, 1] ) and enzyme with fully occupied noncatalytic sites and two filled catalytic sites (MF1 [3, 2] ) were prepared in 150 mM sucrose/10 mM Hepes/1 mM Pi/1 mM MgSO4, pH 8.0 (sucrose/Hepes/Pi/Mg), as described (20) . MF1 [3, 0] was prepared from MF1 [3, 2] by incubating at 20 ,uM for 2 min with 4 mM MgGTP followed by two 5-min incubations in sucrose/Hepes/P,/Mg containing in addition 50 mM Pi. Unbound ligand was removed on a Sephadex centrifuge column (24) between each incubation, and the concentration of Pi was reduced to 1 mM during passage through the last column. Nucleotide-depleted enzyme (MF1[O,O]) was prepared as described by Garrett and Penefsky (25) .
Photoaffinity Labeling. To label a noncatalytic nucleotide site, in a typical experiment 60 ,ul of 14.5 mM 2-azido-[,B,y-32P]ATP was added with rapid mixing to 450 ul of 75 ,uM MF1[2,1] and incubated for 15 min. Unbound ligand was removed on a 3-ml centrifuge column, and MgATP was added to a final concentration of 15 mM to displace 2-azido-ANP from catalytic sites. After 1 min, the enzyme was passed through a second 3-ml centrifuge column and diluted to Purification of 32P-Labeled Peptides. Peptides were purified by reversed-phase HPLC using a Vydac C4 or a Brownlee C8 column (4.6 mm x 25 cm) and a two-pump Waters system as described under Results.
Microsequence Analysis and Fast-Atom Bombardment (FAB) Mass Spectrometry. A gas-phase microsequencer (built at City of Hope) was used for the automated Edman chemical degradations (26) . The phenylthiohydantoin amino acid derivatives were detected and identified by reversed-phase HPLC on an Ultrasphere ODS column (4.6 mm x 25 cm; Altex, Berkeley, CA) and were quantitated by an integration program on a Spectra Physics 4000 computer (27) . FAB mass spectra were taken with a JEOL HX-100HF mass spectrometer utilizing a 6-kV xenon atom primary beam.
Other Methods. 32p was assayed by measuring Cerenkov radiation. MF1 was quantitated using a modified Lowry procedure (28) . ATPase activity was measured at 30°C using an ATP-regenerating system coupled to the oxidation of NADH and monitored spectrally at 340 nm.
2-Azido-AMP was prepared from 2-chloroadenosine and phosphorylated to 2-azido-[,6, y-32P]ATP using 3-phosphoglycerate kinase and adenylate kinase as described (11).
2-Azido-[f3-32PIATP was prepared from 2-azido-[,8-32P]ADP
by incubation with 20 mM potassium phosphoenolpyruvate and 1 ,uM pyruvate kinase at room temperature for 2 hr. 2-Azidoadenine nucleotides were purified by ion-exchange and gel-filtration chromatography using Dowex AG-MP-1 and Sephadex G-10. Concentrations were determined by measuring the absorbance of an equilibrium mixture of the azido and tetraazole isomers (pH 7) at 271 and 310 nm, using extinction coefficients of 10.3 and 7.0 mM-1-cm-1, respectively (18) .
RESULTS

Isolation of Peptides Derived from Modified Catalytic and
Noncatalytic Sites. 2-Azidoadenine nucleotide was specifically loaded at catalytic or noncatalytic sites on MF1, and the complexes were photolyzed and digested with trypsin as described above. The initial tryptic digests were separated by reversed-phase HPLC using a C8 column developed with a gradient of increasing acetonitrile concentration in 0.1% trifluoroacetic acid. Fig. 1 Upper shows the elution of peptides derived from MF1 having a photolabeled noncatalytic site. The major 32P-labeled peaks (solid circles) are eluted when solvent B reaches 14% (T-NC-14) and 20% (T-NC-20). When MF1 having a modified catalytic site is analyzed (Fig. 1 Lower), the major 32P-labeled peak is eluted at 27% B (T-C-27). Similar eluted between 13% and 15% F for T-C-27. These separated components were then subjected to a final HPLC purification using solvents A and B as described for Fig. 1 .
Identification of Sites of Labeling. The purification of peptides from fraction T-NC-20 ( Fig. 1) bound at a noncatalytic site. The second major 32P-labeled fraction derived from the photolabeled noncatalytic site (T-NC-14, Fig. 1 ) was further purified and sequenced. The 32P-labeled peptide proved to be a carboxyl-terminal fragment of the noncatalytic site peptide shown in Table 1 , beginning with Ile-362 (cycle 6).
Several 32P-labeled fractions that migrated close together were obtained upon further purification of the catalytic-site fraction T-C-27 (Fig. 1) . The amino acid sequence of one of the major 32P-labeled peptides (16% of the total radioactivity in the group of peaks) is shown in (Arg) Arg Noncatalytic-and catalytic-site peptides were isolated from fractions T-NC-20 and T-C-27 ( Fig. 1) be aligned with the known MF1 1-subunit sequence beginning with Ala-338. No phenylthiohydantoin derivative was detected at cycle 8 (Xaa). An adjacent 32P-labeled peak (also 16% of the total radioactivity) gave an identical sequence. Both fractions contained minor comigrating impurities that may have been responsible for the small peak separation. For reasons similar to those given above, we surmise that the 8th amino acid in this sequence is a modified tyrosine. These data allow the identification of Tyr-345 as a site of photocrosslinking to the catalytic site. The other minor 32P-labeled peaks, not present in sufficient amounts for sequencing, might represent modification of other residues on the same catalytic peptide. This would be consistent with the results of a 2-azido-ADP labeling study by Vignais' laboratory (22) .
The possibility that the labeling of Tyr-345 or Tyr-368 is due to the modification of a single binding site in two different conformational states is unlikely, since both catalytic and noncatalytic sites can be simultaneously occupied (3). That catalytic and noncatalytic sites are indeed distinct was confirmed by two-dimensional gel electrophoresis (11) of enzyme prepared with both types of sites labeled. Isoelectric focusing showed that some 13 subunits were doubly derivatized and that this was eliminated by an ATP chase to remove 2-azido-ANP from catalytic sites prior to photolysis (data not shown).
Effect of Photolabeling Catalytic or Noncatalytic Sites on Enzyme Activity. Fig. 2 shows the relationship between the extent of derivatization and the inhibition of catalysis for photolabeling catalytic sites (solid squares) and noncatalytic sites (open squares). The same percentage inhibition was obtained when the samples were assayed under conditions for either bi-site (2 ptM MgATP) or tri-site (2 mM MgATP) catalysis. Extrapolation indicates that modification of onethird of the catalytic sites or two-thirds of the noncatalytic sites would suffice for stopping nearly all catalytic activity. The possibility that MF1, completely modified at one catalytic site, might retain a low level of activity was not assessed in these experiments. Such retention has been observed with F1 from chloroplasts (T. Melese, Z.X., and P.D.B., unpublished data).
DISCUSSION
In this study we have shown 13-subunit Tyr-345 to be part of the catalytic site and Tyr-368 to be part of the noncatalytic site of MF1. These residues are conserved in all known sequences for mitochondrial, chloroplast, and bacterial F1 (29) . Further, they are found within highly conserved se- quences, consistent with an essential role in catalysis and perhaps regulation.
A proposed partial structure for the nucleotide-binding domains on the 13 subunit is given in Fig. 3 . The catalytic site, to the right, is shown to be occupied by ATP with Tyr-345 positioned near the adenine ring. The noncatalytic site, composed in part by Tyr-368, is shown to contain bound ADP. The close proximity of the two sites and the positioning of p-subunit residues Thr-299 to Tyr-311 and Gly-161 to Thr-163 are based on the predicted homology between the tertiary structures of the / subunit and adenylate kinase (31, 32) . The likelihood that Thr-299 to Tyr-311 contribute to the catalytic site is strengthened by the sequence homology of residues Thr-298 through to that found at the phosphorylation site of E1E2-type ATPases (33) . In addition, Lys-301, Ile-304, and Tyr-311 of the 3 subunit of MF1 are labeled by 8-azido-ATP (34) . Tyr-311 is also modified by the adenine analog Nbf-Cl, with subsequent transfer of the 4-nitrobenzofurazan group to Lys-162 (35) . Since isolated a subunit from Escherichia coli BF1 has a binding site for adenine nucleotide (13) site. Here we have demonstrated this directly, using an affinity probe that acts as a substrate in the dark and that is bound to specific sites under well-defined conditions. Unlike the studies with FSBI and FSBA, our studies rule out the possibility that two different conformational states of the same nucleotide site are labeled. The catalytic site was modified following the loading of one of the three exchangeable sites on MF1 under conditions for uni-site catalysis (37) , whereas the noncatalytic site was modified following the loading of a single vacant nonexchangeable site present on desalted MF1 (19) . As noted in Results, catalytic and noncatalytic sites can be occupied simultaneously (3), and doubly labeled /3 subunits were detected following photolysis of enzyme with 2-azido-ANP bound at both types of sites.
Vignais and coworkers (22) reported the labeling of /3 Tyr-345 and several other residues on the same tryptic peptide by 2-azido-ADP. Since desalted MF1 normally contains a vacant noncatalytic site and since they added 2-azido-ADP in 4-fold molar excess to MF1, it might have been expected that both 3 Tyr-345 and ,B Tyr-368 would have been detected. The specificity they obtained may have resulted from the procedure used to collect and dissolve the large quantities of MF1 used in their studies. Ammonium sulfate storage medium contains ATP, and if not carefully removed before enzyme is dissolved in a buffer containing Mg2+, a brief episode of catalysis will occur. Inadvertently, this would have resulted in the filling of the vacant noncatalytic site by medium ADP. This explanation is supported by their report (22) that the enzyme used to prepare photolabeled samples for sequencing contained an unusually large amount of endogenous nucleotide (3.7 mol/mol of MF1).
The binding change mechanism, proposed to explain ATP synthesis by oxidative and photophosphorylation (38) , has found fairly widespread use as a working model. One of the main features of this model is strong positive catalytic cooperativity between two (4) or three (7, 8) catalytic subunits. Under conditions where a single site per F1 turns over (uni-site catalysis), the rate of hydrolysis is too slow to detect by a normal coupled enzyme assay (37) . However, rapid turnover occurs under conditions where substrate binding at one catalytic site promotes product release from a second catalytic site (bi-site catalysis). The availability of an affinity probe that binds at a catalytic site and that, following covalent incorporation, completely inactivates that catalytic site could prove useful in further refining certain aspects of the binding change mechanism. For instance, such a probe could be used to determine the minimum number of functional catalytic sites required for bi-site catalysis.
Vignais' laboratory has recently reported that reaction with 2 mol of 2-azido-ATP per MF1 was required for near-complete inhibition (39) . However, in this study they used desalted MF1 that contained the normal amount of endogenous nucleotide. It is likely that their enzyme was in the form MF4[2,1], having two occupied noncatalytic sites and one occupied catalytic site. As Kironde and Cross suggested earlier (19) , 1 of the 2 mol of reagent incorporated in their studies may have reacted at the vacant noncatalytic site. We have reexamined the stoichiometry for inhibition, using MF1 with fully occupied noncatalytic sites (Fig. 2 ) and found that, as for FSBI (21), reaction with only 1 mol of reagent per mol of MFj suffices to block rapid catalysis.
Further, there is no preferential inhibition of tri-site catalysis compared to bi-site catalysis. These results are consistent with those of van Dongen et al. (40) and suggest a strictly ordered participation of the three catalytic sites. It is also of interest that the modification of only two noncatalytic sites per MF1 by 2-azido-ADP may suffice for nearly complete inhibition (Fig. 2) . This would be in contrast to FSBA, which, although it reacts with the same tyrosine residue, requires reaction of close to 3 mol per mol of enzyme for inhibition
